INTRAPULMONARY DELIVERY OF HORMONES

摘要

A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active hormone formulation (4). The formulation is automatically released from a hand-held, self-contained, portable device comprised of a means (7) for automatically releasing a measured amount of a drug into the inspiratory flow path of a patient in response to information obtained from a means (22) for analyzing the inspiratory flow of a patient and after the patient is sent an audible or visual signal. Reproducible dosing is obtained by providing for automatic release in response to a measured inhalation profile. The overadministration of hormone formulations is avoided by providing a preprogrammed microprocessor designed to avoid overdosing.